Joinn Laboratories(China)Co.,Ltd. Stock
Equities
603127
CNE100002W27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.37 CNY | +2.72% | +3.52% | -26.74% |
Sales 2024 * | 2.41B 332M | Sales 2025 * | 2.88B 398M | Capitalization | 12B 1.66B |
---|---|---|---|---|---|
Net income 2024 * | 514M 70.94M | Net income 2025 * | 673M 92.88M | EV / Sales 2024 * | 3.6 x |
Net cash position 2024 * | 3.32B 458M | Net cash position 2025 * | 3.68B 507M | EV / Sales 2025 * | 2.89 x |
P/E ratio 2024 * |
25.3
x | P/E ratio 2025 * |
19.4
x | Employees | 2,510 |
Yield 2024 * |
0.97% | Yield 2025 * |
1.15% | Free-Float | 58.77% |
1 day | +2.72% | ||
1 week | +3.52% | ||
Current month | -3.93% | ||
1 month | -5.34% | ||
3 months | -4.46% | ||
6 months | -29.82% | ||
Current year | -26.74% |
Managers | Title | Age | Since |
---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 12-10-31 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 19-06-30 |
Ye Li
CHM | Chairman | 42 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 95-08-10 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 96-11-30 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 99-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 2 M€ | -16.59% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 17.37 | +2.72% | 18,670,250 |
24-04-25 | 16.91 | -0.82% | 11,812,820 |
24-04-24 | 17.05 | -2.57% | 13,013,380 |
24-04-23 | 17.5 | +3.12% | 16,251,100 |
24-04-22 | 16.97 | +1.13% | 9,044,722 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.74% | 1.66B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 603127 Stock